Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax.

Innocenti I, Morelli F, Autore F, Tomasso A, Corbingi A, Bellesi S, Za T, De Stefano V, Laurenti L.

Leuk Lymphoma. 2019 May 20:1-3. doi: 10.1080/10428194.2019.1612063. [Epub ahead of print] No abstract available.

PMID:
31106622
2.

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia.

Pagotto S, Veronese A, Soranno A, Balatti V, Ramassone A, Guanciali-Franchi PE, Palka G, Innocenti I, Autore F, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R.

Cancers (Basel). 2019 Apr 23;11(4). pii: E575. doi: 10.3390/cancers11040575.

3.

Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience.

Autore F, Innocenti I, Morelli F, Sorà F, Corbingi A, Fianchi L, Criscuolo M, Pagano L, Sica S, Laurenti L.

Hematol Oncol. 2019 Apr 24. doi: 10.1002/hon.2623. [Epub ahead of print] No abstract available.

PMID:
31017684
4.

HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis.

Innocenti I, Morelli F, Autore F, Corbingi A, Pasquale R, Sorà F, Pompili M, Laurenti L.

Leuk Lymphoma. 2019 May;60(5):1340-1342. doi: 10.1080/10428194.2018.1523401. Epub 2019 Feb 7. No abstract available.

PMID:
30730231
5.

Unrelated cord blood transplantation and post-transplant cyclophosphamide.

Bacigalupo A, Sica S, Laurenti L, Sora' F, Giammarco S, Metafuni E, Innocenti I, Autore F, Teofili L, Bianchi M, Chiusolo P.

Haematologica. 2019 Feb;104(2):e77-e78. doi: 10.3324/haematol.2018.202598. Epub 2018 Dec 20. No abstract available.

6.

Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.

Autore F, Chiusolo P, Sorà F, Giammarco S, Laurenti L, Innocenti I, Metafuni E, Piccirillo N, Pagano L, Bacigalupo A, Leone G, Sica S.

Leuk Lymphoma. 2019 May;60(5):1328-1330. doi: 10.1080/10428194.2018.1522436. Epub 2018 Dec 11. No abstract available.

PMID:
30526180
7.

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.

Gentile M, Shanafelt TD, Mauro FR, Reda G, Rossi D, Laurenti L, Del Principe MI, Cutrona G, Angeletti I, Coscia M, Herishanu Y, Chiarenza A, Molica S, Ciolli S, Goldschmidt N, Angrilli F, Giordano A, Rago A, Bairey O, Tripepi G, Chaffee KG, Sameer PA, Vigna E, Zirlik K, Shvidel L, Innocenti I, Recchia AG, Di Raimondo F, Del Poeta G, Cortelezzi A, Neri A, Ferrarini M, Gaidano G, Kay NE, Polliack A, Foà R, Morabito F.

Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149. [Epub ahead of print] No abstract available.

PMID:
30039576
8.

CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.

D'Arena G, Vitale C, Rossi G, Coscia M, Omedè P, D'Auria F, Statuto T, Valvano L, Ciolli S, Gilestro M, Molica S, Bellesi S, Topini G, Panichi V, Autore F, Innocenti I, Musto P, Deaglio S, Laurenti L, Del Vecchio L.

Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2510. [Epub ahead of print]

PMID:
29602219
9.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Gentile M, Shanafelt TD, Reda G, Mauro FR, Zirlik K, Ciolli S, Laurenti L, Del Principe MI, Rossi D, Di Renzo N, Molica S, Angrilli F, Coscia M, Chiarenza A, Giordano A, Cutrona G, Chaffee KG, Parikh SA, Uccello G, Innocenti I, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Herishanu Y, Shvidel L, Tadmor T, Cortelezzi A, Del Poeta G, Gaidano G, Di Raimondo F, Neri A, Ferrarini M, Foà R, Polliack A, Morabito F.

Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20. No abstract available.

PMID:
29588545
10.

Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.

Innocenti I, Rossi D, Trapè G, Autore F, Larocca LM, Gomes V, Cerri M, Falcucci P, Sica S, Gaidano G, Laurenti L.

Hematol Oncol. 2018 Feb 27. doi: 10.1002/hon.2502. [Epub ahead of print]

PMID:
29484684
11.

Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients.

Alberelli MA, Innocenti I, Autore F, Laurenti L, De Candia E.

Haematologica. 2018 Mar;103(3):e119-e122. doi: 10.3324/haematol.2017.179044. Epub 2017 Dec 14. No abstract available.

12.

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

Gentile M, Shanafelt TD, Mauro FR, Laurenti L, Rossi D, Molica S, Vincelli I, Cutrona G, Uccello G, Pepe S, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foà R, Morabito F.

Am J Hematol. 2018 Feb;93(2):E35-E37. doi: 10.1002/ajh.24960. Epub 2017 Nov 23. No abstract available.

13.

Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.

Innocenti I, Autore F, Pasquale R, Morelli F, Efremov DG, Laurenti L.

Expert Rev Hematol. 2017 Dec;10(12):1069-1076. doi: 10.1080/17474086.2017.1398642. Epub 2017 Nov 3. Review.

PMID:
29082795
14.

Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.

Autore F, Innocenti I, Luigetti M, Piccirillo N, Sora F, Chiusolo P, Sica S, Bacigalupo A, Laurenti L.

Hematol Oncol. 2018 Apr;36(2):392-398. doi: 10.1002/hon.2478. Epub 2017 Sep 15. Review.

PMID:
28913957
15.

Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.

D'Arena G, Vitale C, Perbellini O, Coscia M, La Rocca F, Ruggieri V, Visco C, Di Minno NMD, Innocenti I, Pizza V, Deaglio S, Di Minno G, Giudice A, Calapai G, Musto P, Laurenti L, Iorio EL.

Eur J Haematol. 2017 Oct;99(4):306-314. doi: 10.1111/ejh.12918. Epub 2017 Aug 3.

PMID:
28646624
16.

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.

Laurenti L, Innocenti I, Autore F, Ciolli S, Mauro FR, Mannina D, Del Poeta G, D'Arena G, Massaia M, Coscia M, Molica S, Pozzato G, Efremov DG, Vannata B, Marasca R, Galieni P, Cuneo A, Orlando S, Piciocchi A, Boncompagni R, Vincelli D, Liberati AM, Russo F, Foá R.

Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8. No abstract available.

17.

Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.

D'Arena G, Simeon V, Laurenti L, Cimminiello M, Innocenti I, Gilio M, Padula A, Vigliotti ML, De Lorenzo S, Loseto G, Passarelli A, Di Minno MND, Tucci M, De Feo V, D'Auria F, Silvestris F, Di Minno G, Musto P.

Leuk Lymphoma. 2017 Nov;58(11):2633-2641. doi: 10.1080/10428194.2017.1306648. Epub 2017 Apr 3.

PMID:
28367662
18.

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.

Mauro FR, Galieni P, Tedeschi A, Laurenti L, Del Poeta G, Reda G, Motta M, Gozzetti A, Murru R, Caputo MD, Campanelli M, Frustaci AM, Innocenti I, Raponi S, Guarini A, Morabito F, Foà R, Gentile M.

Am J Hematol. 2017 Jun;92(6):529-535. doi: 10.1002/ajh.24714. Epub 2017 Apr 18.

19.

Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

Tisi MC, Hohaus S, Cuccaro A, Innocenti I, De Carolis E, Za T, D'Alò F, Laurenti L, Fianchi L, Sica S, Sanguinetti M, De Stefano V, Pagano L.

Haematologica. 2017 Mar;102(3):e108-e111. doi: 10.3324/haematol.2016.151837. Epub 2016 Nov 17. No abstract available.

20.

Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.

De Luca L, D'Arena G, Simeon V, Trino S, Laurenzana I, Caivano A, La Rocca F, Villani O, Mansueto G, Deaglio S, Innocenti I, Laurenti L, Molica S, Pietrantuono G, De Stradis A, Del Vecchio L, Musto P.

Leuk Lymphoma. 2017 Jun;58(6):1424-1432. doi: 10.1080/10428194.2016.1243790. Epub 2016 Oct 14.

PMID:
27739922
21.

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

Gentile M, Shanafelt TD, Rossi D, Laurenti L, Mauro FR, Molica S, Cutrona G, Uccello G, Campanelli M, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foà R, Morabito F.

Blood. 2016 Oct 20;128(16):2093-2095. doi: 10.1182/blood-2016-07-728261. Epub 2016 Aug 22. No abstract available.

22.

Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.

D'Arena G, Rossi G, Laurenti L, Statuto T, D'Auria F, Valvano L, Simeon V, Giudice A, Innocenti I, De Feo V, Filosa R, Musto P.

J Immunol Res. 2016;2016:9271469. doi: 10.1155/2016/9271469. Epub 2016 Jul 14.

23.

Non-invasive brain stimulation of the aging brain: State of the art and future perspectives.

Tatti E, Rossi S, Innocenti I, Rossi A, Santarnecchi E.

Ageing Res Rev. 2016 Aug;29:66-89. doi: 10.1016/j.arr.2016.05.006. Epub 2016 May 21. Review.

PMID:
27221544
24.

PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia.

Alberelli MA, Innocenti I, Sica S, Laurenti L, De Candia E.

Thromb Res. 2016 Apr;140 Suppl 1:S196. doi: 10.1016/S0049-3848(16)30187-6. Epub 2016 Apr 8.

PMID:
27161742
25.

BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199.

Bojarczuk K, Sasi BK, Gobessi S, Innocenti I, Pozzato G, Laurenti L, Efremov DG.

Blood. 2016 Jun 23;127(25):3192-201. doi: 10.1182/blood-2015-10-675009. Epub 2016 Apr 19.

26.

New developments in the management of chronic lymphocytic leukemia: role of ofatumumab.

Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG.

Onco Targets Ther. 2016 Jan 20;9:421-9. doi: 10.2147/OTT.S72845. eCollection 2016. Review.

27.

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.

Laurenti L, Autore F, Innocenti I, D'Arena G, Coscia M, Mondello P, Chiusolo P, Bellesi S, Efremov DG, Sica S, Mauro FR.

Leuk Lymphoma. 2016 Oct;57(10):2429-31. doi: 10.3109/10428194.2015.1137293. Epub 2016 Jan 27. No abstract available.

PMID:
26818825
28.

Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units.

Salvi G, Innocenti I, Autore F, Laurenti L.

Mediterr J Hematol Infect Dis. 2015 Nov 1;7(1):e2015056. doi: 10.4084/MJHID.2015.056. eCollection 2015.

29.

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.

Laurenti L, Innocenti I, Autore F, Vannata B, Efremov DG, Ciolli S, Del Poeta G, Mauro FR, Cortelezzi A, Borza PA, Ghio F, Mondello P, Murru R, Gozzetti A, Cariccio MR, Piccirillo N, Boncompagni R, Cantonetti M, Principe MI, Reda G, Bongarzoni V, Cervetti G, Pitini V, Foà R, Sica S, D'Arena G.

Leuk Res. 2015 Oct;39(10):1066-70. doi: 10.1016/j.leukres.2015.07.009. Epub 2015 Jul 26.

PMID:
26307523
30.

Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience.

Laurenti L, Autore F, Innocenti I, Vannata B, Piccirillo N, Sorà F, Speziale D, Pompili M, Efremov D, Sica S.

Leuk Lymphoma. 2015;56(10):2841-6. doi: 10.3109/10428194.2015.1017822. Epub 2015 Mar 14.

PMID:
25682966
31.

Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants.

Cioncoloni D, Innocenti I, Bartalini S, Santarnecchi E, Rossi S, Rossi A, Ulivelli M.

J Neurol Sci. 2014 Oct 15;345(1-2):213-9. doi: 10.1016/j.jns.2014.07.050. Epub 2014 Jul 28.

PMID:
25130927
32.

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

Veronese A, Pepe F, Chiacchia J, Pagotto S, Lanuti P, Veschi S, Di Marco M, D'Argenio A, Innocenti I, Vannata B, Autore F, Marchisio M, Wernicke D, Verginelli F, Leone G, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R.

Leukemia. 2015 Jan;29(1):86-95. doi: 10.1038/leu.2014.139. Epub 2014 Apr 15.

33.

Pilot-scale ISCO treatment of a MtBE contaminated site using a Fenton-like process.

Innocenti I, Verginelli I, Massetti F, Piscitelli D, Gavasci R, Baciocchi R.

Sci Total Environ. 2014 Jul 1;485-486:726-738. doi: 10.1016/j.scitotenv.2014.01.062. Epub 2014 Feb 9.

PMID:
24518270
34.

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.

De Padua L, Laurenti L, Falcucci P, D'arena G, Vannata B, Innocenti I, Autore F, Piccirillo N, Za T, Marietti S, Efremov DG, Sica S.

Ann Hematol. 2014 Jul;93(7):1261-2. doi: 10.1007/s00277-013-1968-x. Epub 2013 Dec 5. No abstract available.

PMID:
24306088
35.

Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience.

Laurenti L, Vannata B, Innocenti I, Autore F, Santini F, Piccirillo N, Za T, Bellesi S, Marietti S, Sica S, Efremov DG, Leone G.

Mediterr J Hematol Infect Dis. 2013 May 2;5(1):e2013031. doi: 10.4084/MJHID.2013.031. Print 2013.

36.

The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.

Laurenti L, Vannata B, Innocenti I, Autore F, Santini F, Sica S, Efremov DG.

Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013027. doi: 10.4084/MJHID.2013.027. Print 2013.

37.

Role of the dorsal premotor cortex in rhythmic auditory-motor entrainment: a perturbational approach by rTMS.

Giovannelli F, Innocenti I, Rossi S, Borgheresi A, Ragazzoni A, Zaccara G, Viggiano MP, Cincotta M.

Cereb Cortex. 2014 Apr;24(4):1009-16. doi: 10.1093/cercor/bhs386. Epub 2012 Dec 12.

PMID:
23236203
38.

TMS interference with primacy and recency mechanisms reveals bimodal episodic encoding in the human brain.

Innocenti I, Cappa SF, Feurra M, Giovannelli F, Santarnecchi E, Bianco G, Cincotta M, Rossi S.

J Cogn Neurosci. 2013 Jan;25(1):109-16. doi: 10.1162/jocn_a_00304.

PMID:
23198892
39.

High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia.

Vannata B, Innocenti I, Autore F, Sorà F, Chiusolo P, Leone G, Sica S, Laurenti L.

Am J Hematol. 2012 Dec;87(12):E133. doi: 10.1002/ajh.23349. Epub 2012 Oct 31. No abstract available.

40.

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.

D'Arena G, D'Auria F, Simeon V, Laurenti L, Deaglio S, Mansueto G, Del Principe MI, Statuto T, Pietrantuono G, Guariglia R, Innocenti I, Martorelli MC, Villani O, De Feo V, Del Poeta G, Musto P.

Am J Hematol. 2012 Jun;87(6):628-31. doi: 10.1002/ajh.23170. Epub 2012 Mar 28.

41.

The effect of music on corticospinal excitability is related to the perceived emotion: a transcranial magnetic stimulation study.

Giovannelli F, Banfi C, Borgheresi A, Fiori E, Innocenti I, Rossi S, Zaccara G, Viggiano MP, Cincotta M.

Cortex. 2013 Mar;49(3):702-10. doi: 10.1016/j.cortex.2012.01.013. Epub 2012 Feb 10.

PMID:
22405960
42.

Cortico-Cortical Connectivity between Right Parietal and Bilateral Primary Motor Cortices during Imagined and Observed Actions: A Combined TMS/tDCS Study.

Feurra M, Bianco G, Polizzotto NR, Innocenti I, Rossi A, Rossi S.

Front Neural Circuits. 2011 Aug 30;5:10. doi: 10.3389/fncir.2011.00010. eCollection 2011.

43.

Mycosis fungoides as a cause of severe obstructive sleep apnea.

Luigetti M, Cianfoni A, Scarano E, Laurenti L, Innocenti I, Testani E, Dittoni S, Della Marca G.

Intern Med. 2011;50(16):1753-5. Epub 2011 Aug 15.

44.

New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia.

Laurenti L, De Padua L, D'Arena G, Vannata B, Innocenti I, Tarnani M, Deaglio S, Sica S, Efremov DG, Leone G.

Mini Rev Med Chem. 2011 Jun;11(6):508-18.

PMID:
21561405
45.

Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR.

Serini S, Donato V, Piccioni E, Trombino S, Monego G, Toesca A, Innocenti I, Missori M, De Spirito M, Celleno L, Fasano E, Ranelletti FO, Calviello G.

J Nutr Biochem. 2011 Sep;22(9):874-85. doi: 10.1016/j.jnutbio.2010.08.004. Epub 2010 Dec 24.

PMID:
21185708
46.

Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids.

Fasano E, Serini S, Piccioni E, Innocenti I, Calviello G.

Curr Med Chem. 2010;17(29):3358-76. Review.

PMID:
20712568
47.

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.

Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, D'Arena G, Innocenti I, Marietti S, Efremov DG, Chiusolo P, Zini G, Sora' F, Sica S, Leone G.

Ann Hematol. 2011 Jan;90(1):59-65. doi: 10.1007/s00277-010-1025-y. Epub 2010 Jul 13.

PMID:
20625902
48.

Event-related rTMS at encoding affects differently deep and shallow memory traces.

Innocenti I, Giovannelli F, Cincotta M, Feurra M, Polizzotto NR, Bianco G, Cappa SF, Rossi S.

Neuroimage. 2010 Oct 15;53(1):325-30. doi: 10.1016/j.neuroimage.2010.06.011. Epub 2010 Jun 16.

PMID:
20601000
49.

Temporal dynamics of memory trace formation in the human prefrontal cortex.

Rossi S, Innocenti I, Polizzotto NR, Feurra M, De Capua A, Ulivelli M, Bartalini S, Cappa SF.

Cereb Cortex. 2011 Feb;21(2):368-73. doi: 10.1093/cercor/bhq103. Epub 2010 Jun 7.

PMID:
20530217
50.

Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients.

Palladino M, Laurenti L, Chiusolo P, Piccioni P, Innocenti I, Tarnani M, Sorà F, Sica S, Leone G.

Acta Haematol. 2010;123(4):230-4. doi: 10.1159/000313639. Epub 2010 Apr 29.

PMID:
20424437

Supplemental Content

Loading ...
Support Center